Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0499-v1Release info

Latest

Research title

Research aimed at creating a biobank for bone and soft tissue tumors and elucidating the molecular pathology based on gene expression analysis, as well as improving prognosis

Research overview

Aims
Malignant bone and soft tissue tumors are cancerous diseases that occur in bone and soft tissue, but they only account for around 1% of all cancers. Furthermore, malignant bone and soft tissue tumors are classified in a very complex way based on pathological histology, and there are over 150 types of tissue, including both benign and malignant tumors. As a result, diagnosis is difficult, and there are cases where appropriate treatment cannot be provided. There are many cases of bone and soft tissue tumors with a poor prognosis due to the rarity of the disease, histological diversity, and intractability. The aim of this study is to develop biomarkers to assist in diagnosis and to elucidate the pathology with the aim of developing new treatment methods.
Methods
Sanger sequencing
Participants/materials
Sarcoma 6 cases
URL
N/A

Datasets

CartDataset IDType of dataAnalysis methodAccess criteriaDate published
JGAD000929Sanger sequencing
  • Sanger sequencing
Controlled-access (Type I)2025-04-25

Data provider

Principal investigator
Nobuhiko Hasegawa
Affiliation
Department of Orthopaedics, Faculty of Medicine, Juntendo University

Research projects

NameURL
Development of molecular markers for bone and soft tissue tumors
N/A

Grants

NameTitleProject number
KAKENHI Grant-in-Aid for Early-Career Scientists
Development of molecular markers using blood samples in bone and soft tissue tumors
  • 22K16721
KAKENHI Fund for the Promotion of Joint International Research (Fostering Joint International Research)
Exploration of therapeutic targets and development of biomarkers focusing on fusion genes in bone and soft tissue tumors
  • 23KK0310

Related publications

No related publications.

Controlled access users

No use of the controlled access data has been recorded.